In the primary DILI sub-network of cluster 1, IL6, IL1B, TNF, and CCL2 were among the top ten key targets and related to the COVID-19 adverse outcome pathwaya inflammation of CRS exacerbated DILI. The gene discussed is CCL2; the disease is COVID-19.